The patient with actinic cheilosis

General Dentistry

Volumn 54, Issue 4, 2006, Pages 274-282

  Huber, Michaell A ^a   Terezhalmy, Geza T ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHEILITIS; DIFFERENTIAL DIAGNOSIS; HUMAN; MOUTH TUMOR; PATHOLOGY; PHOTOSENSITIVITY DISORDER; PRECANCER; SUNLIGHT; ULTRAVIOLET RADIATION;

CHEILITIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MOUTH NEOPLASMS; PHOTOSENSITIVITY DISORDERS; PRECANCEROUS CONDITIONS; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 33748665256     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (97)

1. Picascia DD, Robinson JK. Actinic cheilitis: A review of the etiology, differential diagnosis, and treatment. J Am Acad Dermatol 1987;17:255-264.
2. Rogers RS 3rd, Bekic M. Diseases of the lips. Semin Cutan Med Surg 1997;16:323-336.
3. de Visscher JG, van der Waal I. Etiology of cancer of the lip. A review. Int J Oral Maxillofac Surg 1998;27:199-203.
4. Ackerman AB. Opposing views of 2 academies about the nature of solar keratosis. Cutis 2003;71:391-395.
5. Cohn BA. From sunlight to actinic keratosis to squamous cell carcinoma. J Am Acad Dermatol 2000;42(1 Pt 1):143-144.
6. Fu W, Cockerell CJ. The actinic (solar) keratosis: A 21st century perspective. Arch Dermatol 2003;139:66-70.
7. Leffell DJ. The scientific basis of skin cancer. J Am Acad Dermatol 2000;42(1 Pt 2):18-22.
8. Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000;42:8-10.
9. Stern RS. Clinical practice. Treatment of photoaging. New Engl J Med 2004;350:1526-1534.
10. Veness M. Lip cancer: Important management issues. Australas J Dermatol 2001;42:30-32.
11. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001;344:975-983.
12. Bernstein SC, Lim KK, Brodland DG, Heidelberg KA. Cutaneous squamous-cell carcinoma. Dermatol Surg 1996;22:243-254.
13. de Visscher JG, Schaapveld M, Otter R, Visser O, van der Waal I. Epidemiology of cancer of the lip in The Netherlands. Oral Oncol 1998;34:421-426.
14. Einspahr JG, Stratton SP, Bowden T, Alberts DS. Chemoprevention of human skin cancer. Crit Rev Oncol Hematol 2002;41:269-285.
15. Luna-Ortiz K, Guemes-Meza A, Villavicencio-Valencia V, Mosqueda-Taylor A. Lip cancer experience in Mexico. An 11-year retrospective study. Oral Oncol 2004;40:992-999.
16. Ostwald C, Gogacz P, Hillmann T, Schweder J, Gundlach K, Kundt G, Barten M. p53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity. Int J Cancer 2000;88:82-86.
17. Tutrone WD, Saini R, Caglar S, Weinberg JM, Crespo J. Topical therapy for actinic keratoses, I: 5-fluorouracil and imiquod. Cutis 2003;71:365-370.
18. Tutrone WD, Saini R, Caglar S, Weinberg JM, Crespo J. Topical therapy for actinic keratoses, II: Diclofenac, colchicines, and retinoids. Cutis 2003;71:373-379.
19. Clydesdale GJ, Dandie GW, Muller HK. Ultraviolet light induced injury: Immunological and inflammatory effects. Immunmol Cell Biol 2001;79:547-568.
20. Marrot L, Belaidi JP, Lejeune F, Meunier JR, Asselineau D, Bernerd F. Photostability of sunscreen products influences the efficiency of protection with regard to UV-induced genotoxic or photoageing-related end-points. Br J Dermatol 2004;151:1234-1244.
21. Schober-Flores C. The sun's damaging effects. Dermatol Nurs 2001;13:279-286.
22. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000;42:4-7.
23. Sarasin A. The molecular pathways of ultraviolet-induced carcinogenesis. Mutat Res 1999;428:5-10.
24. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001;63:8-18.
25. Ortonne JP. From actinic keratosis to squamous cell carcinoma. Br J Dermatol 2002;146 Suppl 61:20-23.
26. Crosthwaite N, Teale D, Franklin C, Foster GA, Stringer BM. p53 protein expression in malignant, pre-malignant and non-malignant lesions of the lip. J Clin Pathol 1996;49:648-653.
27. Sunscreen drug products for over-the-counter human use. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart= 352&showFR=1. Accessed Dec 15, 2005.
28. de Gruijl FR, van Kranen HJ, Mullenders LH. UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol B 2001;63:19-27.
29. Perea-Milla Lopez E, Minarro-Del Moral RM, Martinez-Garcia C, Zanetti R, Rosso S, Serrano S, Aneiros JF, Jimenez-Puente A, Redondo M. Lifestyles, environmental and phenotypic factors associated with lip cancer: A case-control study in southern Spain. Br J Cancer 2003;88:1702-1707.
30. Markopoulos A, Albanidou-Farmaki E, Kayavis I. Actinic cheilitis: Clinical and pathologic characteristics in 65 cases. Oral Dis 2004;10:212-216.
31. Howell RE, Wright BA, Dewar R. Trends in the incidence of oral cancer in Nova Scotia from 1983 to 1997. Oral Surg Oral Med Oral Pathol Radiol Endod 2003;95:205-212.
32. Ocana-Riola R, Sanchez-Cantalejo C, Rosell J, Sanchez-Cantalejo E, Daponte A. Socio-economic level, farming activities and risk of cancer in small areas of Southern Spain. Eur J Epidemiol 2004;19:643-650.
33. Dreno B. Skin cancers after transplantation. Nephrol Dial Transplant 2003;18:1052-1058.
34. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003;348:1681-1691.
35. Preciado DA, Matas A, Adams G. Squamous cell carcinoma of the head and neck in solid organ transplant recipients. Head Neck 2002;24:319-325.
36. Adami J, Gabel H, Lindelof B, Ekstrom K, Rydh B, Glimelius B, Ekbom A, Adami HO, Granath F. Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer 2003;89:1221-1227.
37. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000;143:513-519.
38. Gupta AK, Cooper EA, Feldman SR, Fleischer AB Jr. A survey of office visits for actinic keratosis as reported by NAMCS, 1990-1999. National Ambulatory Medical Care Survey. Cutis 2002;70:8-13.
39. dos Santos JN, de Sousa SO, Nunes FD, Sotto MN, de Araujo VC. Altered cytokeratin expression in actinic cheilitis. J Cutan Pathol 2003;30:237-241.
40. 2 laser for the treatment of actinic cheilitis. Dermatol Surg 2000;26:349-353.
41. Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000;42:8-10.
42. Kaugars GE, Abbey LM, Page DG, Svirsky JA, Burns JC, Pillion T. Prevention and detection of lip cancer-The dentist's role. J Calif Dent Assoc 1999;27:318-323.
43. Bedekovic V, Dzepina D, Ivkic M, Trotic R, Petric V, Kekic B. Squamous cell carcinoma of the lip in long-standing oral lichen planus: Case report, surgical approach. J Otolaryngol 2003;32:345-348.
44. Huber M. Oral lichen planus. Quintessence Int 2004;35:731-752.
45. Nissalo S, Hietanen J, Malmstrom M, Hukkanen M, Polak J, Konttinen YT. Disorder-specific changes in innervation in oral lichen planus and lichenoid reactions. J Oral Pathol Med 2000;29:361-369.
46. Leao JC, Ferreira AM, Martins S, Jardim ML, Barrett AW, Scully C, Porter SR. Cheilitis glandularis: An unusual presentation in a patient with HIV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:142-144.
47. Stoopler ET, Carrasco L, Stanton DC, Pringle G, Sollecito TP. Cheilitis glandularis: An unusual histopathologic presentation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:312-317.
48. Ayangco L, Rogers RS 3rd. Oral manifestations of erythema multiforme. Dermatol Clin 2003;21:195-205.
49. Gately LE III, Nesbit LT Jr. Update on immunofluorescenct testing in bullous diseases and lupus erythematosus. Dermatol Cin 1994;12:133-142.
50. Bickle KM, Roark TR, Hsu S. Autoimmune bullous dermatoses: A review. Am Fam Physician 2002;65:1861-1870.
51. Casiglia J, Woo SB, Ahmed AR. Oral involvement in autoimmune blistering diseases. Clin Dermatol 2001;19:737-741.
52. Orteu CH, Buchanan JA, Hutchison I, Leigh IM, Bull RH. Systemic lupus erythematosus presenting with oral mucosal lesions: Easily missed? Br J Dermatol 2001;144:1219-1223.
53. Hasseus B, Jontell M, Brune M, Johansson P, Dahlgren UI. Langerhans cells and T cells in oral graft versus host disease and oral lichen planus. Scand J Immunol 2001;54:516-524.
54. Rocha N, Mota F, Horta M, Lima O, Massa A, Sanches M. Plasma cell cheilitis. J Eur Acad Dermatol Venerol 2001;18:96-98.
55. El-Hakim M, Chauvin P. Orofacial granulomatosis presenting as persistent lip swelling: Review of 6 new cases. J Oral Maxilofac Surg 2004;62:1114-1117.
56. van der Waal RI, Schulten EA, van der Meij EH, van de Scheur MR, Starink TM, van der Waal I. Cheilitis granulomatosa: Overview of 13 patients with long-term follow-up-Results of management. Inter J Dermatol 2002;41:225-229.
57. Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000;42:11-17.
58. Yantsos VA, Conrad N, Zabawski E, Cockerell CI. Incipient intraepidermal cutaneous squamous cell carcinoma: A proposal for reclassifying and grading solar (actinic) keratoses. Semin Cutan Med Surg 1999;18:3-14.
59. McCombe D, MacGill K, Ainslie J, Beresford I, Matthews J. Squamous cell carcinoma of the lip: A retrospective review of the Peter MacCallum Cancer Institute experience 1979-88. Aust N Z J Surg 2000;70:358-361.
60. Fernandez-Angel I, Rodriguez-Archilla A, Aneiros Cachaza J, Munoz Medina M, Serrano Ortega S. Markers for metastasis in lip cancer. Eur J Dermatol 2003;13:276-279.
61. Guney E, Yigitbasi OG. Functional surgical approach to the level I for staging early carcinoma of the lower lip. Otolaryngol Head Neck Surg 2004;131:503-508.
62. Rodolico V, Barresi E, Di Lorenzo R, Leonardi V, Napoli P, Rappa F, Di Bernardo C. Lymph node metastasis in lower lip squamous cell carcinoma in relation to tumour size, histologic variables and p27Kip1 protein expression. Oral Oncol 2004;40:92-98.
63. Zitsch RP 3rd, Lee BW, Smith RB. Cervical lymph node metastases and squamous cell carcinoma of the lip. Head Neck 1999;21:447-453.
64. de Visscher JG, van den Elsaker K, Grond AJ, van der Wal JE, van der Waal I. Surgical treatment of squamous cell carcinoma of the lower lip: Evaluation of long-term results and prognostic factors-A retrospective analysis of 184 patients. J Oral Maxillofac Surg 1998;56:814-820.
65. Bilkay U, Kerem H, Ozek C, Gundogan H, Guner U, Gurler T, Akin Y. Management of lower lip cancer: A retrospective analysis of 118 patients and review of the literature. Ann Plast Surg 2003;50:43-50.
66. Meves A, Repacholi MH, Rehfuess EA. Global Solar UV Index: A physician's tool for fighting the skin cancer epidemic. Int J Dermatol 2003;42:846-849.
67. American Cancer Society. How do I protect myself from UV? Available at: http://www.cancer.org/docroot/PED/content/ped_7_1x_Protect_Your_Skin_From_UV. asp?sitearea=PED. Accessed December 15, 2005.
68. Prevention and treatment of sunburn. Med Lett Drugs Ther 2004;46:45-46.
69. Rosen CF. Topical and systemic photoprotection. Dermatol Ther 2003;16:8-15.
70. Young AR. Are broad-spectrum sunscreens necessary for immunoprotection? J Invest Dermatol 2003;121:ix-x.
71. Buka RL. Sunscreens and insect repellents. Curr Opin Pediatr 2004;16:378-384.
72. Sunscreen agents (topical). Available at: http://www.healthtouch.com/bin /EContent_HT/drugShowLftsasp?fname =usp0810.htm&title=Octocrylene%2C +Octyl+Methoxycinnamate%2C+and +Oxybenzone&cid=L. Accessed December 15, 2005.
73. Ting WW, Vest CD, Sontheimer R. Practical and experimental consideration of sun protection in dermatology. Int J Dermatol 2003;42:505-513.
74. Terezhalmy GT, Naylor GD. Actinic cheilitis. J Indiana Dent Assoc 1993;72:12-15.
75. Diffey B. Sunscreen isn't enough. J Photochem Photobiol B 2001;64:105-108.
76. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993;329:1147-51.
77. David LM. Laser vermilion ablation for actinic cheilitis. J Dermatol Surg Oncol 1985;11:605-608.
78. Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol 2000;42(1 Pt 2):25-28.
79. Dufresne RG Jr, Curlin MU. Actinic cheilitis. A treatment review. Dermatol Surg 1997;23:15-21.
80. Gloster HM Jr. The use of second-intention healing for partial-thickness Mohs defects involving the vermilion and/or mucosal surfaces of the lip. J Am Acad Dermatol 2002;47:893-897.
81. Gooris PJ, Roodenburg JL, Vermey A, Nauta JM. Carbon dioxide laser evaporation of leukoplakia of the lower lip: A retrospective evaluation. Oral Oncol 1999;35:490-495.
82. Gupta AK. The management of actinic keratoses in the United States with topical fluoruracil: A pharmacoeconomic evaluation. Cutis 2002;70:30-36.
83. Kuwahara RT, Rasberry RD. Cryosurgery acne attachment for actininc cheilitis. Dermatol Surg 2000;26:899.
84. Labandeira J, Pereiro M Jr, Valdes F, Toribio J. Intermittent topical 5-fluorouracil is effective without significant irritation in the treatment of actinic keratoses but prolongs treatment duration. Dermatol Surg 2004;30:517-520.
85. Levy S, Furst K, Chern W. A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulation. Clin Ther 2001;23:901-907.
86. Levy S, Furst K, Chern W. Apharmacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in patients with actinic keratosis. Clin Ther 2001;23:908-920.
87. Levy S, Furst K, Chern W. A novel 0.5% fluorouracil cream is minimally absorbed into the systemic circulation yet is as effective as 5% fluorouracil cream. Cutis 2002;70(2 Suppl):14-21.
88. Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol 1982;7:631-632.
89. Ries WR, Speyer MT. Cutaneous applications of lasers. Otolaryngol Clin North Am 1996;29:915-929.
90. Robins P, Gupta AK. The use of topical fluorouracil to treat actinic keratosis. Cutis 2002;70(2 Suppl):4-7.
91. Robinson JK. Actinic cheilitis. A prospective study comparing four treatment methods. Arch Otolaryngol Head Neck Surg 1989;115:848-852.
92. Roodenburg JL, Panders AK, Vermey A. Carbon dioxide laser surgery of oral leukoplakia. Oral Surg Oral Med Oral Pathol 1991;71:670-674.
93. Stanley RJ, Roenigk RK. Actinic cheilitis: Treatment with carbon dioxide laser. Mayo Clin Proc 1988;63:230-235.
94. Weiss J, Menter A, Hevia O, Jones T, Ling M, Rist T, Roberts J, Shavin JS, Sklar J, Webster G, Connolly M, Furst K, Levy S. Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1,2, or 4 weeks. Cutis 2002;70:22-29.
95. Yu TC, Rahman Z, Ross BS. Actinic keratoses-Surgical and physical therapeutic modalities. Cutis 2003;71:381-384.
96. Zelickson BD, Roenigk RK. Actininc cheilitis. Treatment with carbon dioxide laser. Cancer 1990;65:1307-1311.
97. Johnson MR, Hageboutros A, Wang K, High L, Smith JB, Diasio RB. Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil. Clin Cancer Res 1999;5:2006-2011.